Microstim GmbH, a Wismar, Germany based medical technology company, has raised €1.5m in funding.
Backers include the German state Mecklenburg-Vorpommern, Technologiefonds MV, High-Tech-Gruenderfonds and Fides Finanz-Invest.
The company intends to use the funds for the development, construction and the first clinical application of its muscle stimulator, planned in 2012.
Led by Dr. Klapproth, co-founder and managing director, Microstim develops a new, tissue-maintaining and function-preserving implantable muscle stimulator for muscle powered cardiac assistance in collaboration with the Clinic of Cardiac Surgery, Lübeck, Germany of the University Hospital Schleswig-Holstein, Germany. A feature of the patented stimulation system is that the implant permanently monitors the stimulation loading of the muscle and counteracts a therapy threatening overstimulation.
FinSMEs
06/10/2011